Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MIRM

+ Watchlist+ Portfolio

Mirum Pharmaceuticals, Inc.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$91.95
52-Week Range
$63.23 – $130.00
Market Cap
$6.04B
P/E (TTM)
—
EPS (TTM)
-14.47
Dividend Yield
0.00%
Advanced Metrics
Price/Book
—
PEG Ratio
—
Return on Equity
-760.01%
Return on Assets
-10.01%
Gross Margin
81.72%
Operating Margin
-21.63%
Profit Margin
-134.75%
Current Ratio
2.07
Debt/Equity
—
Total Debt
$743.56M
Free Cash Flow
$98.39M
Revenue Growth
39.60%
Earnings Growth
—
Enterprise Value
$6.41B

Market Snapshot

About

Mirum Pharmaceuticals develops and commercializes therapies for rare liver diseases. The company focuses on cholestatic liver conditions and other orphan hepatic disorders with high unmet medical needs.